2026 / 05

DOI: 10.24075/brsmu.2026.058
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Antitumor activity of prototype drugs based on the Newcastle disease virus in the AKATOL tumor model

Yurchenko KS1 , Adamenko LS1 , Kovalenko VS1 , Budko AI2 , Gagloeva TD2 , Timaeva OI2 , Trashkov AP2 , Shestopalov AM1
About authors

1 Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Novosibirsk, Russia

2 Kurchatov Institute, Moscow, Russia

Correspondence should be addressed: Ksenia S. Yurchenko
Timakova, 2, Novosibirsk, 630060, Russia; ur.mtfcrf@oknehcruisk

About paper

Funding: the work was supported under the State Assignment No. 075-00486-26-00 of the Ministry of Science and Higher Education of the Russian Federation.

Author contribution: Yurchenko KS — study concept and design, article authoring, visualization; Adamenko LS — preparation of virus-containing drugs; Kovalenko VS — review and analysis of literature, article authoring; Budko AI — experiments on mice, statistical analysis; Gagloeva TD — experiments on mice, preparation of samples of drugs; Timaeva OI — study concept, text editing; Trashkov AP — study design, experiments on mice, formal analysis, text editing; Shestopalov AM — formulation of study goals and objectives, text editing, project management.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Federal Research Center of Fundamental and Translational Medicine (Minutes No. 26 of September 29, 2026). The animals were kept, cared for, manipulated and removed from the experiment in accordance with the principles of humane treatment of laboratory animals set out in the Directive 86/609/EEC and the Declaration of Helsinki.

Received: 2026-08-27 Accepted: 2026-10-07 Published online: 2026-10-18
|
  1. Guo L, Wang L, Cai L, et al. Global distribution of colorectal cancer staging at diagnosis: an evidence synthesis. Clin. Gastroenterol. Hepatol. 2025; 23 (12): 2088–101. DOI: 10.1016/j.cgh.2024.11.019.
  2. Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion. 2025; 106 (2): 91–99. DOI: 10.1159/000543921.
  3. Fedyanin MYu, Gladkov OA, Gordeev SS, i dr. Rak obodochnoj kishki, rektosigmoidnogo soedineniya i pryamoj kishki. Klinicheskie rekomendacii RUSSCO, chast' 1.1. Zlokachestvennye opuholi 2025; 15 (3s2): 310–72. DOI: 10.18027/2224-5057-2025-15-3s2-1.1-14. Russian.
  4. Vozdvizhenskiĭ MO. Pyatiletnie rezul'taty lecheniya bol'nyh s metastazami kolorektal'nogo raka v pecheni. Zhurnal im. P.A. Gercena. 2013; 2 (1): 44–46. Russian.
  5. Appleton E, Chiocca EA, Ungerechts G, et al. Oncolytic viruses as anticancer agents: clinical progress and remaining challenges. Lancet. 2025; 406 (10509): 1295–312. DOI: 10.1016/S0140-6736(25)01206-1.
  6. Alwithenani A, Hengswat P, Chiocca EA. Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation. Mol Ther. 2025; 33 (5): 2217–28. DOI: 10.1016/j.ymthe.2025.03.035.
  7. Salameh H, Naseem N, Chattha MA, et al. Oncolytic virotherapy in colorectal cancer: mechanistic insights, enhancer strategies, and translational combinations. Cells. 2025; 14 (24): 2006. DOI: 10.3390/cells14242006.
  8. Yang H, Tian J, Zhao J, et al. The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy. Viruses. 2024; 16 (6): 886. DOI: 10.3390/v16060886.
  9. Liang W, Wang H, Sun TM, et al. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract. World J Gastroenterol. 2003; 9 (3): 495–8. DOI: 10.3748/wjg.v9.i3.495.
  10. Davar D, Carneiro BA, Dy GK, et al. Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors. J Immunother Cancer. 2024; 12 (11): e009336. DOI: 10.1136/jitc-2024-009336.
  11. Santry LA, van Vloten JP, AuYeung AWK, et al. Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumorspecific immune responses in two murine models of cancer. Front Microbiol. 2024; 15: 1325558. DOI: 10.3389/fmicb.2024.1325558.
  12. Niu Z, Bai F, Sun T, et al. Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model. Technology in Cancer Research & Treatment. 2015; 14 (5): 607–15. DOI: 10.7785/tcrt.2012.500414.
  13. Yurchenko KS, Sivay MV, Glushchenko AV, et al. Complete genome sequence of a Newcastle disease virus isolated from a rock dove (Columba livia) in the Russian Federation. Genome Announc. 2015; 3 (1): e01514–14. DOI: 10.1128/genomeA.01514-14.
  14. Castle JC, Loewer M, Boegel S, et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics. 2014; 15 (1): 190. DOI: 10.1186/1471-2164-15-190.
  15. Fetisov TI, Tilova LR, Lesovaya EA, i dr. Protivoopuholevoe dejstvie kuraksina CBL0137 na modelyah adenokarcinomy tolstoj kishki. Uspekhi molekulyarnoj onkologii. 2016; 3 (3): 67–72. DOI: 10.17650/2313-805X-2016-3-3-67–72. Russian
  16. Trashkov AP, Kovalenko AL, Dragomiretskaya EI, i dr. Vliyanie meglyumina akridonacetata na razvitie ehksperimental'noj adenokarcionomy tolstoj kishki i opuhol'-associirovannyh izmenenij sistemy krovi u myshej linii BALB/c. Patogenez. 2019; 17 (2): 51– 61. DOI:10.25557/2310-0435.2019.02.51-61. Russian.
  17. Nakanishi K, Tomita M, Tsumoto K. Membrane fusion and infection abilities of baculovirus virions are preserved during freezing and thawing in the presence of trehalose. Biosci Biotechnol Biochem. 2020; 84 (4): 686–94. Available from: https://doi.org/10.1080/09168451.2019.1704396.
  18. Pastorino B, Baronti C, Gould EA, Charrel RN, de Lamballerie X. Effect of Chemical Stabilizers on the Thermostability and Infectivity of a Representative Panel of Freeze Dried Viruses. PLOS ONE. 2015; 10 (4): e0118963. Available from: https://doi.org/10.1371/journal.pone.0118963.
  19. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nusw) mice. Cancer Chemother Pharmacol. 1989; 24: 148–154. DOI: 10.1007/BF00300234.
  20. Kooti W, Esmaeili HGG, Farzanehpour M, et al. Oncolytic Newcastle disease virus effects on immune response — a new issue in cancer treatment. Klin Onkol. 2023; 36 (2): 124–9. DOI: 10.48095/ccko2023124.
  21. Yurchenko KS, Zhou P, Kovner AV, et al. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model. PLoS One. 2018; 13 (4): e0195425. DOI: 10.1371/journal.pone.0195425.
  22. Xu Q, Rangaswamy US, Wang W, et al. Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo. Int J Cancer. 2020; 146 (2): 531–41. DOI: 10.1002/ijc.32694.
  23. Kovalenko VS, Yurchenko KS, Adamenko LS, Glushchenko AV, Shestopalov AM. Razrabotka i optimizaciya lekarstvennoj formy onkoliticheskogo preparata na osnove virusa bolezni N'yukasla. «Vliyanie izmeneniya klimata na biologicheskoe raznoobrazie i rasprostranenie virusnyh infekcij zhivotnyh v Evrazii». Materialy V Mezhdunarodnoj nauchnoj konferencii 5–7 dekabrya 2023. Novosibirsk, s. 19.
  24. Awad K, Abdelhadi M, Awad AM. High Glucose Reduces Influenza and Parainfluenza Virus Productivity by Altering Glycolytic Pattern in A549 Cells Int J Mol Sci. 2025; 26: 2975. DOI: 10.3390/ijms26072975.
  25. Mozaffari Nejad AS, Fotouhi F, Mehrbod P, Alikhani MY. Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors. Saudi J Biol Sci. 2021; 28 (10): 5833–40. DOI: 10.1016/j.sjbs.2021.06.043.
  26. Jorio H, Tran R, Kamen A. Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol Prog. 2006; 22: 319–25. DOI: 10.1021/bp050218v.
  27. Qin ZL, Ju HP, Liu Y, Gao TT, Wang WB, Aurelian L, Zhao P, Qi ZT. Fetal bovine serum inhibits hepatitis C virus attachment to host cells. Journal of Virological Methods. 2007; 193 (2): 261–9. DOI: 10.1016/j.jviromet.2013.06.024.
  28. Ravlić S, Brgles M, Hiršl L, et al. Production- and PurificationRelevant Properties of Human and Murine Cytomegalovirus. Viruses. 2021; 13 (12): 2481. DOI: 10.3390/v13122481.
  29. Moustapha A, Talaki E, Akourki A, et al. Newcastle disease virus in poultry: Current status and control prospects. World’s Veterinary Journal. 2023; 13 (2): 240–9. Available from: https://www.doi.org/10.54203/scil.2023.wvj26.
  30. Liang S, Lin X, Liang Y, et al. Killing Effects of IFN R-/- Mouse NK Cells Activated by HN Protein of NDV on Mouse Hepatoma Cells and Possible Mechanism with Syk and NF-κB. Anat Rec (Hoboken). 2019; 302 (10): 1718–25. DOI: 10.1002/ar.24177.